A group of EpiPen purchasers have hit drug maker Mylan with a class-action lawsuit, claiming the company engaged in illegal price fixing to inflate the price of its allergy treatment over a decade by 574 percent. According to the complaint filed in Washington state on Monday, Mylan acquired the rights to market and distribute EpiPen […]
